全文获取类型
收费全文 | 10646篇 |
免费 | 1020篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 110篇 |
儿科学 | 340篇 |
妇产科学 | 275篇 |
基础医学 | 1654篇 |
口腔科学 | 227篇 |
临床医学 | 1193篇 |
内科学 | 2025篇 |
皮肤病学 | 187篇 |
神经病学 | 677篇 |
特种医学 | 548篇 |
外科学 | 1315篇 |
综合类 | 215篇 |
一般理论 | 5篇 |
预防医学 | 1008篇 |
眼科学 | 159篇 |
药学 | 889篇 |
中国医学 | 9篇 |
肿瘤学 | 871篇 |
出版年
2021年 | 119篇 |
2020年 | 97篇 |
2019年 | 138篇 |
2018年 | 166篇 |
2017年 | 123篇 |
2016年 | 148篇 |
2015年 | 142篇 |
2014年 | 213篇 |
2013年 | 332篇 |
2012年 | 473篇 |
2011年 | 491篇 |
2010年 | 278篇 |
2009年 | 252篇 |
2008年 | 410篇 |
2007年 | 461篇 |
2006年 | 481篇 |
2005年 | 455篇 |
2004年 | 464篇 |
2003年 | 433篇 |
2002年 | 411篇 |
2001年 | 388篇 |
2000年 | 434篇 |
1999年 | 346篇 |
1998年 | 137篇 |
1997年 | 163篇 |
1996年 | 138篇 |
1995年 | 126篇 |
1994年 | 103篇 |
1993年 | 109篇 |
1992年 | 285篇 |
1991年 | 278篇 |
1990年 | 226篇 |
1989年 | 234篇 |
1988年 | 246篇 |
1987年 | 218篇 |
1986年 | 197篇 |
1985年 | 186篇 |
1984年 | 140篇 |
1983年 | 138篇 |
1982年 | 105篇 |
1981年 | 95篇 |
1980年 | 88篇 |
1979年 | 143篇 |
1978年 | 92篇 |
1977年 | 93篇 |
1976年 | 97篇 |
1975年 | 71篇 |
1974年 | 100篇 |
1973年 | 81篇 |
1969年 | 70篇 |
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
1.
2.
Louis Anthony Cox Jr. 《Critical reviews in toxicology》2019,49(7):614-635
AbstractCan a single fiber of amphibole asbestos increase the risk of lung cancer or malignant mesothelioma (MM)? Traditional linear no-threshold (LNT) risk assessment assumptions imply that the answer is yes: there is no safe exposure level. This paper draws on recent scientific progress in inflammation biology, especially elucidation of the activation thresholds for NLRP3 inflammasomes and resulting chronic inflammation, to model dose-response relationships for malignant mesothelioma and lung cancer risks caused by asbestos exposures. The modeling integrates a physiologically based pharmacokinetics (PBPK) front end with inflammation-driven two-stage clonal expansion (I-TSCE) models of carcinogenesis to describe how exposure leads to chronic inflammation, which in turn promotes carcinogenesis. Together, the combined PBPK and I-TSCE modeling predict that there are practical thresholds for exposure concentration below which asbestos exposure does not cause chronic inflammation in less than a lifetime, and therefore does not increase chronic inflammation-dependent cancer risks. Quantitative examples using model parameter estimates drawn from the literature suggest that practical thresholds may be within about a factor of 2 of some past exposure levels for some workers. The I-TSCE modeling framework explains previous puzzling aspects of asbestos epidemiology, such as why age at first exposure is a better predictor of lifetime MM risk than exposure duration. It may be a valuable tool for risk analysts when LNT assumptions are not justified due to inflammation response thresholds mediating dose-response relationships. 相似文献
3.
Andrew Harner Youli Wang Xuexiu Fang Todd D. Merchen Philip B. Cox Sam Ho Daniel Kleven Thomas Thompson N. Stanley Nahman 《Transplantation proceedings》2019,51(6):2124-2131
BackgroundAcute rejection of a kidney allograft results from adaptive immune responses and marked inflammation. The eicosanoid prostaglandin E2 (PGE2) modulates the inflammatory response, is generated by cyclooxygenase 2 (COX-2), and binds to 1 of the 4 G protein-coupled E prostanoid cell surface receptors (EP1-4). Receptor activation results in in proinflammatory (EP1 and EP3) or anti-inflammatory (EP2 and EP4) responses. We theorized that expression of the components of the COX-PGE2-EP signaling pathway correlates with acute rejection in a porcine model of allogeneic renal transplantation.MethodCOX-2 enzyme and EP receptor protein expression were quantitated with western blotting and immunohistochemistry from allotransplants (n = 18) and autotransplants (n = 5). Linear regression analysis was used to correlate EP receptor expression with the Banff category of rejection.ResultsPigs with advanced rejection demonstrated significant increases in serum PGE2 metabolites, while pigs with less rejection demonstrated higher tissue concentrations of PGE2 metabolites. A significant negative correlation between COX-2 expression and Banff category of rejection (R = ?0.877) was shown. Rejection decreased expression of EP2 and EP4. For both receptors, there was a significant negative correlation with the extent of rejection (R = ?0.760 and R = ?0.891 for EP2 and EP4, respectively). Rejection had no effect on the proinflammatory receptors EP1 and EP3.ConclusionDownregulation of COX-2 and the anti-inflammatory EP2 and EP4 receptors is associated with acute rejection in unmatched pig kidney transplants, suggesting that the COX-2-PGE2-EP pathway may modulate inflammation in this model. Enhancing EP2 and/or EP4 activity may offer novel therapeutic approaches to controlling the inflammation of acute allograft rejection. 相似文献
4.
5.
Gang Chen Robert W. Cox Daniel R. Glen Justin K. Rajendra Richard C. Reynolds Paul A. Taylor 《Human brain mapping》2019,40(3):1037-1043
One‐sided t‐tests are widely used in neuroimaging data analysis. While such a test may be applicable when investigating specific regions and prior information about directionality is present, we argue here that it is often mis‐applied, with severe consequences for false positive rate (FPR) control. Conceptually, a pair of one‐sided t‐tests conducted in tandem (e.g., to test separately for both positive and negative effects), effectively amounts to a two‐sided t‐test. However, replacing the two‐sided test with a pair of one‐sided tests without multiple comparisons correction essentially doubles the intended FPR of statements made about the same study; that is, the actual family‐wise error (FWE) of results at the whole brain level would be 10% instead of the 5% intended by the researcher. Therefore, we strongly recommend that, unless otherwise explicitly justified, two‐sided t‐tests be applied instead of two simultaneous one‐sided t‐tests. 相似文献
6.
7.
Raffaella Marcheselli Alessia Bari Tamar Tadmor Luigi Marcheselli Maria Christina Cox Robel Papotti Angela Ferrari Luca Baldini Paolo Gobbi Ilana Levy Giuseppe Pugliese Massimo Federico Aaron Polliack Samantha Pozzi Stefano Sacchi 《Hematological oncology》2020,38(4):439-445
The main purpose of this study was to assess whether it is possible to improve the prognostic impact of international prognostic index (IPI) score by combining it with peripheral blood counts. Thus, we evaluated the prognostic power of lymphocyte, neutrophil, and monocyte counts in 520 patients with diffuse large B cell lymphoma treated with R-CHOP, confirming that these parameters have a strong impact on overall survival (OS). Using revised IPI (R-IPI), 44% of patients were categorized as poor-risk and showed an OS at 5 years of 46%. As OS at 5 years of the 520 patients is 67%, it is clearly evident that R-IPI tends to overestimate the proportion of patients with poor prognosis. Accordingly, in an attempt to improve the discriminating power of R-IPI, we evaluated and compared three different scores by combining the neutrophil lymphocyte ratio (NLR) and absolute monocyte count (AMC) with the following values: (a) IPI score 3-5, (b) age > 60 years and performance status, (c) age ≥ 65 years and LDH > ULN. The three indexes studied, had a similar 5 years OS for the high-risk group (46%-52%), but the proportion of patients classified as poor-risk were 37%, 20%, and 32%, respectively, which are lower than 44% identified with R-IPI. Thus, while R-IPI overestimates the number of high-risk patients, after applying our models, it is possible to recognize patients who are truly at high-risk. Of the three scores, the most accurate appears to be that based on NLR, AMC, LDH > ULN and age ≥ 65 years, which identifies 32% of high-risk patients, correlating well with what is seen in clinical practice. 相似文献
8.
9.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168
Background
Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.Methods
We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).Results
Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.Conclusions
Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation. 相似文献10.